scispace - formally typeset
S

Steven K. Herrine

Researcher at Thomas Jefferson University

Publications -  73
Citations -  2843

Steven K. Herrine is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Hepatitis C & Ribavirin. The author has an hindex of 23, co-authored 71 publications receiving 2596 citations. Previous affiliations of Steven K. Herrine include Thomas Jefferson University Hospital.

Papers
More filters
Journal ArticleDOI

The Devil is in the Third Year: A Longitudinal Study of Erosion of Empathy in Medical School

TL;DR: It is concluded that a significant decline in empathy occurs during the third year of medical school, and it is ironic that the erosion of empathy occurs when the curriculum is shifting toward patient-care activities; this is when empathy is most essential.
Journal ArticleDOI

Effects of antiviral therapy on the cellular immune response in acute hepatitis C

TL;DR: A sustained response to antiviral therapy was not associated with a lasting enhancement of HCV‐specific T‐cell responsiveness in the blood, as previously reported.
Journal ArticleDOI

Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate

TL;DR: Among HCV genotype 1-infected patients treated with PEG-IFN/RBV, anemia was associated with higher rates of sustained virologic responses (SVR), and the effect of ESAs varied by time to anemia; patients with early-onset anemia hadHigher rates of SVR with ESA use, whereas no effect was observed in those with late-onsets anemia.
Journal ArticleDOI

Pregnancy after liver transplantation

TL;DR: Pregnancy in the setting of recurrent liver disease, such as recurrent hepatitis C, poses a potential problem among liver transplant recipients, as well as the possible adverse effects of immunosuppression on maternal kidney function.
Journal ArticleDOI

The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database

TL;DR: A careful examination of the OPTN database, with respect to HLA match or mismatch and liver graft survival, reaffirms that HLA matching has no clinically significant impact on this outcome.